Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NasdaqCM - Delayed Quote USD

P3 Health Partners Inc. (PIII)

Compare
0.1835
+0.0194
+(11.82%)
At close: 4:00:01 PM EDT
Loading Chart for PIII
  • Previous Close 0.1641
  • Open 0.1669
  • Bid --
  • Ask --
  • Day's Range 0.1669 - 0.1903
  • 52 Week Range 0.1520 - 0.8910
  • Volume 681,053
  • Avg. Volume 2,488,520
  • Market Cap (intraday) 101.849M
  • Beta (5Y Monthly) 0.93
  • PE Ratio (TTM) --
  • EPS (TTM) -1.0800
  • Earnings Date May 6, 2025 - May 12, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 0.62

P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.

p3hp.org

400

Full Time Employees

December 31

Fiscal Year Ends

Recent News: PIII

View More

Performance Overview: PIII

Trailing total returns as of 4/1/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

PIII
18.44%
S&P 500 (^GSPC)
4.23%

1-Year Return

PIII
79.27%
S&P 500 (^GSPC)
7.42%

3-Year Return

PIII
97.76%
S&P 500 (^GSPC)
23.92%

5-Year Return

PIII
98.17%
S&P 500 (^GSPC)
128.01%

Compare To: PIII

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PIII

View More

Valuation Measures

Annual
As of 3/31/2025
  • Market Cap

    26.75M

  • Enterprise Value

    154.10M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.02

  • Price/Book (mrq)

    0.35

  • Enterprise Value/Revenue

    0.10

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -6.96%

  • Return on Assets (ttm)

    -18.25%

  • Return on Equity (ttm)

    -65.45%

  • Revenue (ttm)

    1.48B

  • Net Income Avi to Common (ttm)

    -102.69M

  • Diluted EPS (ttm)

    -1.0800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    62.96M

  • Total Debt/Equity (mrq)

    54.79%

  • Levered Free Cash Flow (ttm)

    36.38M

Research Analysis: PIII

View More

Company Insights: PIII

Research Reports: PIII

View More

People Also Watch